TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) MALVERN, Pa., Dec. 12, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Compensation Committee of the Board of Directors of TELA Bio approved inducement grants of restricted stock units covering 3,600 shares of its common stock to three newly-hired employees, with a grant date of December 9, 2025 (the "Grant Date"). The restricted stock units were granted pu...
TELA Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference MALVERN, Pa., Nov. 19, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will participate in Piper Sandler’s 37th Annual Healthcare Conference. TELA’s management is scheduled to present at Piper Sandler’s 37th Annual Healthcare Conference at 2:30 pm ET on December 3rd, 2025. Interested parties can access the live and archived webcast at . About TELA Bio, In...
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) MALVERN, Pa., Nov. 17, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Compensation Committee of the Board of Directors of TELA Bio approved inducement grants of (i) restricted stock units covering 30,200 shares of its common stock to seventeen newly-hired employees and (ii) an option to purchase 25,000 shares of its common stock to one employee, with a gra...
TELA Bio Announces Pricing of $13.0 Million Underwritten Registered Direct Offering of Common Stock and Pre-Funded Warrants MALVERN, Pa., Nov. 13, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced the pricing of an underwritten registered direct offering of 4,189,000 shares of its common stock at a price of $1.11 per share and, in lieu of common stock to investors who so choose, pre-funded warrants to purchase 7,523,000 shares of common stock at an offering p...
TELA Bio Reports Third Quarter 2025 Financial Results and Refinancing and Upsizing of Credit Facility MALVERN, Pa., Nov. 13, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today reported financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Financial Highlights Revenue of $20.7 million, a 9% increase from the third quarter of 2024Revised full year 2025 revenue guidance of at least 16% growth over full year 2024 Recent Strategic Highli...
TELA Bio to Announce Third Quarter 2025 Financial Results MALVERN, Pa., Nov. 04, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will report third quarter 2025 financial results on Thursday, November 13, 2025. TELA Bio’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update. Third Quarter Earnings Conference Call and Webcast DetailsInve...
TELA Bio Appoints William Plovanic to Board of Directors MALVERN, Pa., Nov. 03, 2025 (GLOBE NEWSWIRE) -- MALVERN, Pa., November 3, 2025 (GLOBE NEWSWIRE) — TELA Bio, Inc. (“TELA Bio”) (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced the appointment of William (“Bill”) Plovanic, CFA, to its Board of Directors. Mr. Plovanic brings a distinctive combination of capital markets expertise and operational leadership in medical technology. He currently serves as Managing Director, Healthcare Equity ...
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
Mister Car Wash Announces Third Quarter 2025 Results Net revenues increased 6%Comparable-store sales increased 3.1%Unlimited Wash Club® (“UWC”) memberships increased 6%Opened 5 new greenfield locationsReiterates full year 2025 outlook TUCSON, Ariz., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Mister Car Wash, Inc. (the “Company”) (Nasdaq: MCW), the nation’s leading car wash brand, today announced its financial results for the quarter ended September 30, 2025. “We delivered a solid third quarter performance, underscoring the strength of our strategy, the resilience of our business model, and the d...
Mister Car Wash Acquires Five Stores from Whistle Express, Expanding Presence in Lubbock, Texas TUCSON, Ariz., Oct. 21, 2025 (GLOBE NEWSWIRE) -- . (NASDAQ: MCW), the nation’s premier car wash company, today announced the acquisition of five Whistle Express locations in Lubbock, Texas currently operated under the Take 5 Car Wash brand. The transaction expands Mister Car Wash’s footprint in the Lubbock market from four to nine convenient locations, establishing a leading market position across the city. Stephens Inc. served as exclusive financial advisor to Whistle Express on the divestitur...
A director at Darden Restaurants Inc sold 1,700 shares at 184.580USD and the significance rating of the trade was 50/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years ...
Mister Car Wash to Report Third Quarter 2025 Financial Results on October 29, 2025 TUCSON, Ariz., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Mister Car Wash, Inc. (the "Company" or "Mister"; Nasdaq: MCW), the nation’s leading car wash brand, today announced that its financial results for the third quarter of 2025 will be released after market close on Wednesday, October 29, 2025. On the same day, the Company will host a conference call at 4:30 p.m. Eastern Time to discuss the financial results. Investors and analysts interested in participating in the call are invited to dial 855-209-8213 (intern...
TELA Bio Announces Addition of Betty Jo Rocchio to Board of Directors and the Departure of Director Lisa Colleran MALVERN, Pa., Oct. 09, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (“TELA Bio”) (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced the appointment of Betty Jo Rocchio, DNP, RN, CRNA, CENP, EBP-C, to its Board of Directors, and the departure of Lisa Colleran, who has stepped down following five years of service on the Board. Dr. Rocchio is a nationally recognized healthcare leader and ...
THOR Industries Announces Regular Quarterly Dividend ELKHART, Ind., Oct. 08, 2025 (GLOBE NEWSWIRE) -- THOR Industries, Inc. (NYSE: THO) today announced that its Board of Directors approved, at its October 8, 2025, meeting, the payment of a regular quarterly cash dividend of $0.52 per share. The regular cash dividend is payable on November 6, 2025, to shareholders of record at the close of business on October 23, 2025. About THOR Industries, Inc. THOR is the sole owner of operating companies which, combined, represent the world's largest manufacturer of recreational vehicles. For more ...
THOR Industries Announces Fiscal 2025 Fourth Quarter and Full Year Results REPORTS SOLID RESULTS AMIDST IMPROVING MARKET SHARE, RETAIL SALES TRENDSFinancial Highlights ($ in thousands, except for per share data) Three Months EndedJuly 31, Change Fiscal Years EndedJuly 31, Change 2025 2024 2025 2024 Net Sales $2,523,783 $2,534,167 (0.4)% $9,579,490 $10,043,408 (4.6)% Gross Profit $370,883 $401,331 (7.6)% $1,340,641 $1,451,962 (7.7)% Gross Profit Margin % 14.7% 15.8% (110) bps 14.0% 14.5% (50) bps Net Income Attributable to THOR $125,757 $90,015...
THOR Industries Announces Date for its Fiscal 2025 Fourth Quarter Earnings Release ELKHART, Ind., Sept. 10, 2025 (GLOBE NEWSWIRE) -- THOR Industries, Inc. (NYSE: THO) today announced that the date for its fiscal 2025 fourth quarter earnings release will be on Wednesday, September 24, 2025, before the market opens. Upon the release of THOR's fiscal 2025 fourth quarter earnings, the Company will concurrently publish a copy of the earnings release, a comprehensive question and answer document and a slide presentation on the Company's website. To view the quarterly earnings documents, please...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.